Representing Kansas bioscience companies and research institutions
Home About KansasBio Membership Center Bioscience News Contact KansasBio
Information Resources Education & Training Networking & Collaboration Business & Investment


Up-to-the minute latest news in the biotechnology sector and from biotech companies in Kansas and around the world

  KansasBio photos  


Biotechnology Headlines from PR Newswire

Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices
Unilife Accelerates Investment to Meet Increasing Demand from New and Existing Customers
Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call
Synageva BioPharma™ Reports Second Quarter 2014 Financial Results
Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission
Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device
Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake
Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant
Ebola Virus Gene Replikin Count Increased Sixteen-fold in 2013 in Advance of Current Outbreaks
InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada
Chicago Bears Join the American Academy of Dermatology in Fight against Skin Cancer
GRAMMY® Award-Winning Singer Jennifer Hudson Lends Her Voice To Stand Up To Cancer And Genentech In "Two Worlds. One Dream." Campaign In The Fight Against Cancer
Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract
UMD Researchers Bridge Gap between Microelectronics, Biological Systems
DigiPath No New Corporate Developments
Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation
Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms
Access Pharmaceuticals Featured On
Thomas Dubinski joins Dyadic as Chief Financial Officer
invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors
CHMP Recommends Approval of Lilly's Humalog® 200 units/ml KwikPen®
Orexigen Receives CHMP Day 180 List of Outstanding Issues English
RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars
AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001
Ready-to-Use EZ-Fit™ Filtration Unit from EMD Millipore Leverages Industry Leading Technology for More Efficient Bioburden Testing of Liquids
Ready-to-Use EZ-Fit™ Filtration Unit from EMD Millipore Leverages Industry Leading Technology for More Efficient Bioburden Testing of Municipal Water, Environmental Samples and Beverages
PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit
Scientific Innovation Resolves Shaving Irritation
Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37
Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Sequenom Enters Into License Agreement With Mayo Medical Laboratories
Pfenex Announces Closing of Initial Public Offering
Covance Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro Forma EPS Growth of 21.5% to $0.95 and Adjusted Net Orders of $773 Million English
Franz Och, Ph.D., Expert in Machine Learning and Machine Translation, Joins Human Longevity, Inc. as Chief Data Scientist
QIAGEN Reports Second Quarter and First Half 2014 Results and Announces Launch of new $100 Million Share Repurchase Program
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL
TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit
Hantian Labs Ltd. Introduces Trailblazing Anti-Aging and Vitality Product For Men, GHBurn
Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time
Digital Pathology Market worth $437 Million by 2018
Nanosyn Announces Expanded Partnership With FORMA Therapeutics
SAGE® Labs Licenses CRISPR/Cas9 Technology from the Broad Institute
Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo
Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
EastGate Acquisitions Announces Expansion of its Pharmaceutical Developments Implementing its Sub-Micron Platform Technology
Instrumentation Laboratory Unveils New Corporate Brand
Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research
ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC

< Prev Next >
PR Newswire - United Business Media

Kansas Bioscience Association

© 2004 Kansas Bioscience Organization (KansasBio). All rights reserved.